HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden

Background/Objectives: Whether age at type 1 diabetes (T1D) diagnosis reflects overall HLA class II epitope burden or additional sequence information remains unclear. We investigated whether HLA-DRB1 β57, a position in HLA-DR distinct from the established DQB1 β57 susceptibility position in HLA-DQ, contributes information about age at diagnosis beyond class II epitope burden. Methods: Phased DRB1–DQA1–DQB1 data were analysed in 97 early-onset T1D patients (EOT1D; ≤5 years) and 96 later-onset patients (LaOT1D; 8–30 years), recruited specifically within these age groups, and 169 controls from Portugal. Analyses included burden-adjusted multinomial models, complementary continuous-age regression, natural DRB1*04 sequence comparisons, and repeated nested cross-validation with independently tuned leave-one-position-out ablations; log loss was the primary cross-validation metric. Results: Epitope burdens distinguished T1D from controls but showed no statistically supported difference between EOT1D and LaOT1D. Adding DRB1 β57D improved multinomial fit (p = 2.28 × 10−8); the adjusted EOT1D-versus-LaOT1D relative risk ratio was 3.17 per copy (95% CI 1.65–6.09). DRB1 β57D dosage correlated inversely with age at diagnosis (ρ = −0.231; p = 0.0012) and was associated with diagnosis 2.28 years earlier per copy in the adjusted continuous-age model (95% CI −4.17 to −0.38; p = 0.0187). Expanded natural DRB1*04 comparisons involved β57, β71 and β86. Removing β57 increased cross-validated log loss by 0.0783 (Benjamini–Hochberg-adjusted q = 0.028) and reduced the area under the receiver operating characteristic curve from 0.6643 to 0.5134; no other removal survived correction in the primary patient comparison. Adjusted subgroup analyses did not establish an association after excluding *04:08/*04:05 carriers or among non-DR4 participants. Conclusions: Within this Portuguese cohort, DRB1 β57 contributed information about age at T1D diagnosis beyond the specified class II epitope burdens. These findings refine the previously observed DRB1*04 allele associations and warrant independent replication and functional investigation.

Authors

Institutions

Publication Details

Journal
Genes
Published
2026-11-18
DOI
https://doi.org/10.3390/genes17111460
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden

Íris Caramalho, Dário Ligeiro, Ana Laura Fitas, Carlos Penha‐Gonçalves et al.
Genes
Diabetes and associated disorders
article

HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden

Íris Caramalho, Dário Ligeiro, Ana Laura Fitas, Carlos Penha‐Gonçalves, Tiago Paixão, Jocelyne Demengeot, Paula Matoso, Daniel Sobral, Catarina Limbert
article en

Abstract

Background/Objectives: Whether age at type 1 diabetes (T1D) diagnosis reflects overall HLA class II epitope burden or additional sequence information remains unclear. We investigated whether HLA-DRB1 β57, a position in HLA-DR distinct from the established DQB1 β57 susceptibility position in HLA-DQ, contributes information about age at diagnosis beyond class II epitope burden. Methods: Phased DRB1–DQA1–DQB1 data were analysed in 97 early-onset T1D patients (EOT1D; ≤5 years) and 96 later-onset patients (LaOT1D; 8–30 years), recruited specifically within these age groups, and 169 controls from Portugal. Analyses included burden-adjusted multinomial models, complementary continuous-age regression, natural DRB1*04 sequence comparisons, and repeated nested cross-validation with independently tuned leave-one-position-out ablations; log loss was the primary cross-validation metric. Results: Epitope burdens distinguished T1D from controls but showed no statistically supported difference between EOT1D and LaOT1D. Adding DRB1 β57D improved multinomial fit (p = 2.28 × 10−8); the adjusted EOT1D-versus-LaOT1D relative risk ratio was 3.17 per copy (95% CI 1.65–6.09). DRB1 β57D dosage correlated inversely with age at diagnosis (ρ = −0.231; p = 0.0012) and was associated with diagnosis 2.28 years earlier per copy in the adjusted continuous-age model (95% CI −4.17 to −0.38; p = 0.0187). Expanded natural DRB1*04 comparisons involved β57, β71 and β86. Removing β57 increased cross-validated log loss by 0.0783 (Benjamini–Hochberg-adjusted q = 0.028) and reduced the area under the receiver operating characteristic curve from 0.6643 to 0.5134; no other removal survived correction in the primary patient comparison. Adjusted subgroup analyses did not establish an association after excluding *04:08/*04:05 carriers or among non-DR4 participants. Conclusions: Within this Portuguese cohort, DRB1 β57 contributed information about age at T1D diagnosis beyond the specified class II epitope burdens. These findings refine the previously observed DRB1*04 allele associations and warrant independent replication and functional investigation.

GenesVol. 17(11)
Champalimaud Foundation (PT), University of Lisbon (PT), Instituto de Medicina Tropical (PY), Hospital de Dona Estefânia (PT), National Institute of Health Dr. Ricardo Jorge (PT), Instituto Portugues do Sangue e da Transplantacao, IP (PT), Gulbenkian Institute for Molecular Medicine (PT), Centro de Sangue e da Transplantação de Lisboa Área Funcional do Sangue (PT), Comprehensive Health Research Centre (PT), Instituto Gulbenkian de Ciência (PT), Universidade Nova de Lisboa (PT)
European Foundation for the Study of Diabetes, Fundação para a Ciência e a Tecnologia
Good health and well-being
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon